Abstract
Use of intravenous (IV) cangrelor has been confined to interventional cardiology in the cardiac catheterization area.1, 2 However, information on IV cangrelor use outside of this setting is limited.2, 3 We report a case of using IV cangrelor in replacement of dual antiplatelet therapy (DAPT) as a
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
